Androgenetic alopecia (AGA) is a common cause of hair loss worldwide. It mainly affects the frontal and parietal regions of the scalp in up to 70 % of men and 40 % of women and has a significant negative psychological and emotional impact on those affected. Various therapies are currently approved for the treatment of AGA in men and women, including topical minoxidil, topical or systemic finasteride, platelet-rich plasma and hair transplantation. In addition to these pharmacological and surgical interventions, laser therapies including thulium laser with growth factors have gained popularity. Despite the clinical use of the thulium laser with growth factors in combination with LED phototherapy, there are only a few studies to date that have adequately investigated the objective and patient-side benefits of this therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
3 sessions at intervals of 6 weeks
3 sessions at intervals of 6 weeks
3 sessions at intervals of 6 weeks
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany
RECRUITINGSubject Global Aesthetic Improvement Scale
scale from 0 (very much improved) to 4 (worse)
Time frame: 1 and 6 months post-treatment
Hair density
measurement of hair density before and after treatment
Time frame: at baseline, and 1 and 6 months post-treatment
hair thickness
hair thickness before and after treatment
Time frame: at baseline, and 1 and 6 months post-treatment
pain intensity
pain intensity during treatment using a numeric rating scale from 0 (no pain) to 10 (unbearable pain)
Time frame: Periprocedural
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.